跳至主要内容
临床试验/TCTR20221016001
TCTR20221016001已完成2 期

Effectiveness of metformin, DLBS 3233 and Vaccinium myrtillus extract to improve the Rotterdam criteria and HOMA-IR score in women with chronic polycystic ovarian syndrome (PCOS)

ocal, in Arifin Achmad Hospital0 个研究点目标入组 39 人开始时间: 2022年10月16日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 44 Years(—)
性别
Female

入选标准

  • All patients who satisfied the Rotterdam PCOS criteria for chronic polycystic ovarian syndrome, which includes oligomenorrhea or amenorrhea and at least one of the two symptoms of hyperandrogenism (clinical or biochemical proof of it) or polycystic ovaries on ultrasound, ready to take part in research and willing to follow research protocol, and HOMA-IR > 2.0.

排除标准

  • (1) People with comorbid conditions; (2). Treatment for insulin sensitivity within three months before the study or during the study; (3) Drug hypersensitivity reactions that are well-known; and (4) A body mass index that is less than 20 or higher than 50 kg/m2.

研究者

发起方
ocal, in Arifin Achmad Hospital

相似试验